Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00312247 · ClinicalTrials.gov registry record
Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy
A clinical trial, sponsored by Shriners Hospitals for Children.
- Completed
- Registry status
- 85
- Enrollment target
NCT00312247: Completed study, sponsored by Shriners Hospitals for Children.
NCT00312247 is a clinical trial that has completed, run by Shriners Hospitals for Children. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00312247 has completed, sponsored by Shriners Hospitals for Children.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand the walking patterns, strength and function changes of boys with Duchenne muscular dystrophy on/off corticosteroids to determine the best timing and treatment options to maintain walking for as long as possible.
Primary Outcome
computerized assessment of walking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2006-04 |
| Est. Completion | 2015-03 |
What the finished NCT00312247 record still lists
NCT00312247 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00312247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00312247 about?
NCT00312247 is a clinical study titled "Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy". The purpose of this research study is to understand the walking patterns, strength and function changes of boys with Duchenne muscular dystrophy on/off corticosteroids to determine the best timing and treatment options to maintain walking for as long as possible.
What is the current status of trial NCT00312247?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2006-04. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT00312247?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia